Overview

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The sponsor electively terminated the study because the risk mitigation measures, deemed necessary after an unforeseen safety event, could not be effectively implemented within this protocol while maintaining study timelines within a reasonable time frame.
Phase:
Phase 1
Details
Lead Sponsor:
EMD Serono
Treatments:
Mycophenolate mofetil
Mycophenolic Acid